[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Swiss Medical Academy Maroc\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":52},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":14,"eligibilityCriteria":15,"healthyVolunteers":10,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":30,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":41,"lastUpdatePostDateStruct":42,"startDateStruct":45,"completionDateStruct":47,"leadSponsor":49,"locationsCount":5},"100612785",false,"NCT07258095","INNOV5-MH-MAROC: Integrated Mental Health Care for Adolescents and Adults in Primary Care Centers and Schools in Morocco","INNOV5-MH-MAROC: Multicenter Pragmatic Randomized Controlled Trial Evaluating an Integrated Program of Five WHO Innovations in Mental Health in Morocco","INNOV5-MH","Inclusion Criteria:\n\n* Adolescents (12-17 years) and adults (≥18 years) attending participating primary care centres or high schools in Morocco.\n* Clinically significant depressive and\u002For anxiety symptoms identified by screening (PHQ-9 and\u002For GAD-7) according to study thresholds.\n* Able to understand study procedures and provide informed consent (or parental consent and adolescent assent for minors).\n* Planning to remain in the study area for at least 12 months.\n\nExclusion Criteria:\n\n* Acute psychiatric emergency requiring immediate specialised care (e.g. psychosis, high-risk suicidal crisis, severe substance use disorder).\n* Cognitive impairment or severe medical condition preventing participation in the intervention or assessments.\n* Current participation in another interventional mental health trial.\n* Any other situation judged by the investigator to make participation unsafe or inappropriate.","ALL","12 Years",{"count":19,"type":20},146,"ESTIMATED","INTERVENTIONAL",[23],"NA","Depression and anxiety are highly prevalent among adolescents and adults in Morocco, while access to evidence-based care in primary care centers and schools remains limited. This multicenter pragmatic randomized controlled trial evaluates an integrated mental health program inspired by WHO priorities. The INNOV5 intervention combines: (1) a collaborative care model in primary care; (2) mhGAP-based task-shifting and stepped care; (3) validated digital mental health interventions; (4) virtual reality exposure therapy for selected anxiety- or trauma-related cases; and (5) a school-based mental health promotion component in participating high schools. The primary objective is to compare the change in depressive symptoms (PHQ-9) at 6 months between INNOV5 and enhanced treatment as usual (TAU+). Secondary objectives include effects on anxiety (GAD-7), quality of life (WHOQOL-BREF), suicidal ideation and behavior (C-SSRS), functioning, school attendance, and feasibility and acceptability of the program.",[26,27,28,29],"Depression in Adolescence","Depression in Adults","Anxiety","Mental and Behavioural Disorders",[31,28,32,33,34,35,36,37,38,39],"Depression","Adolescent mental health","Primary care","School-based mental health","Digital mental health","Virtual reality exposure","mhGAP","Task-shifting","Morocco","NOT_YET_RECRUITING","2025-11-20",{"date":43,"type":44},"2025-12-02","ACTUAL",{"date":46,"type":20},"2028-03-01",{"date":48,"type":20},"2029-12-31",{"name":50,"class":51},"Swiss Medical Academy Maroc","OTHER",""]